viewBraveheart Investment Group

Braveheart Investment says investee company expects to be selling new, specially-coated anti-COVID-19 masks by the end of the year

This follows a flurry of activity at Braveheart investee company Pharm2Farm

Braveheart Investment Group -
The masks are for use by both healthcare professionals and the public, Braveheart said

Braveheart Investment Group PLC (LON:BRH) has said a new antiviral face mask that can kill coronavirus (COVID-19) will go on sale by the end of the year.

This follows a flurry of activity at Braveheart investee company Pharm2Farm (P2F), which has developed a textile coating incorporating nanoparticles with long-lasting virucidal properties.

It now has testing results from two independent labs that show the mask textile has a ‘kill rate’ of over 90% for up to seven hours, meeting the requirements for ISO 18184 certification.

The International Organization for Standardization (ISO) sets the international benchmark for antiviral activity in fabrics.

P2F has now submitted a patent application to protect the intellectual property around the unique coating.

Practically, an automated mask production line capable of producing 5mln units a month will be in production by the end of December.

Finally, Braveheart’s sale of its 51.72% stake in P2F to Remote Monitored Systems PLC (LON:RMS) is expected to complete on November 5. As a result Braveheart will own 37.12% of RMS.

Quick facts: Braveheart Investment Group

Price: 37 GBX

Market: AIM
Market Cap: £13.36 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...


Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill...

Braveheart Investment Group PLC (LON:BRH) investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19). Cave talks through the technology behind the mask, which is says is much stronger than the standard...

on 26/10/20

2 min read